Cannabis Law Report

JANUARY 30, 2019

Access the full document at. To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. Access the full document at.

Research and Development 63

Research and Development DEA CBD Law 63

Canna Law Blog

AUGUST 31, 2023

This all looks pretty good right now, but the Drug Enforcement Administration (DEA) and ultimately the Attorney General (AG) have final say on whether to schedule or reschedule marijuana following the HHS recommendation. In any case, the DEA Administrator reports to the AG (through the Deputy AG). The AG could then reschedule.

DEA 122

DEA Marijuana Banking Research and Development 122

Cannabis Law Report

MARCH 25, 2019

The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. 1] professionals.

Banking 45

Banking Law Marijuana State Laws 45

Veriheal

NOVEMBER 7, 2024

The Drug Enforcement Administration (DEA) announced in August that a hearing regarding the reclassification decision will take place on December 2, 2024, before an administrative law judge. Then, the DEA will review the report and draft a final ruling, factoring in all relevant information submitted during the public comment period.

DEA 96

DEA Policy Chronic Pain Marijuana 96